Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # DNA
  • # Diabetes
  • # Hoffmann-La Roche
  • linkedin
  • facebook
  • instagram
  • twitter
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

New Skeletal Tissue Advances Regenerative Medicine Potential

10 January 2025

Micropipette – An Overview | Working, Parts, Calibration, Types, and Applications

6 April 2024

New drugs for antibiotic-resistant bacteria, developed using generative AI

31 March 2024

New therapy to prevent Antibody-Mediated-Rejection (AMR) of kidney transplant

31 May 2024

A new immunotherapy to prevent CAR T-cell therapy inactivity due to resistant leukemia

24 March 2024

Activity in the gut microbiome and brain can influence resilient individuals

26 June 2024

Researchers Find Possible Connections Between Skin Ageing and Microbiome

15 January 2024

Malaria – Parasite, Vector and the ongoing battle against a silent killer

20 June 2023

Amyotrophic Lateral Sclerosis Can be Diagnosed With Blood Test

27 February 2025

An International Study Reveals That a Breakthrough in Childhood Brain Cancer Research Could Revolutionize Treatment

5 February 2025

AstraZeneca Released KALOS and LOGOS Phase III Clinical Trials Result Shows Positive High-level Results of Breztri for Treating Asthma

2 May 2025

Diet and exercise can prevent type 2 diabetes in individuals with high genetic risk

9 August 2024

Cancer

FDA Advisory Committee Recommends Johnson & Johnson’s DARZALEX FASPRO® for High-Risk Smoldering Multiple Myeloma
Cancer Healthcare & Pharmaceuticals News Regulatory

FDA Advisory Committee Recommends Johnson & Johnson’s DARZALEX FASPRO® for High-Risk Smoldering Multiple Myeloma

Athulya B S 22 May 2025

Potentially Groundbreaking Treatment Could Delay or Prevent Progression to Full-Blown Myeloma.

CellCentric Secures $120 Million Investment to Develop Oral Myeloma Drug Inobrodib
Business Cancer Healthcare & Pharmaceuticals

CellCentric Secures $120 Million Investment to Develop Oral Myeloma Drug Inobrodib

Athulya B S 19 May 2025

CellCentric has secured $120 million in Series C funding to accelerate clinical development of Inobrodib, its first-in-class oral p300/CBP inhibitor for treating multiple myeloma. The investment will support upcoming Phase II/III trials and global expansion.

Roche’s VENTANA MET (SP44) RxDx Assay Receives FDA Approval as First Companion Diagnostic for MET-Positive NSCLC
Cancer Clinical Trials Healthcare & Pharmaceuticals News

Roche’s VENTANA MET (SP44) RxDx Assay Receives FDA Approval as First Companion Diagnostic for MET-Positive NSCLC

Athulya B S 15 May 2025

The VENTANA MET (SP44) RxDx Assay detects the MET, or c-Met, protein, which is overexpressed in about 25% of advanced NSQ-NSCLC patients with EGFR wild-type.

AbbVie’s EMRELIS™ (telisotuzumab vedotin-tllv) Receives U.S. FDA’s Accelerated Approval for Adults With Small Cell Lung Cancer (NSCLC)
Cancer Healthcare & Pharmaceuticals News Regulatory Approval

AbbVie’s EMRELIS™ (telisotuzumab vedotin-tllv) Receives U.S. FDA’s Accelerated Approval for Adults With Small Cell Lung Cancer (NSCLC)

Ajmal Aseem 15 May 2025

EMRELIS™ (telisotuzumab vedotin-tllv) used for previously treated adult patients with advanced non-small cell lung cancer (NSCLC) exhibiting high c-Met protein overexpression.

Johnson & Johnson Launches MENTOR™ MemoryGel™ Breast Implants for Reconstruction Patients
Cancer Healthcare & Pharmaceuticals Medical Devices News

Johnson & Johnson Launches MENTOR™ MemoryGel™ Breast Implants for Reconstruction Patients

Athulya B S 14 May 2025

The creation of these implants is a direct answer to the demands of patients who need primary or revision reconstruction following a mastectomy.

Recent Cancer Research Shows Treatment Efficacy With Lupus-Related Antibody
Cancer Research

Recent Cancer Research Shows Treatment Efficacy With Lupus-Related Antibody

Athulya B S 27 March 2025

Immunotherapies and other cancer treatments don’t work well on “cold” tumors, also known as immunological deserts, because they usually have few T cells.

Pfizer With Arvinas Announced Positive Results of Phase 3 VERITAC-2 Clinical Trial for Advanced or Metastatic Breast Cancer
Cancer Clinical Trials Healthcare & Pharmaceuticals News

Pfizer With Arvinas Announced Positive Results of Phase 3 VERITAC-2 Clinical Trial for Advanced or Metastatic Breast Cancer

Editor's Desk 11 March 2025

At the time of the analysis, less than 25% of the necessary number of events had taken place, indicating that overall survival was not mature.

A Rare Side Effect for Cancer Immunotherapy Detected
Cancer Immunotherapy Research

A Rare Side Effect for Cancer Immunotherapy Detected

Ajmal Aseem 24 February 2025

The researchers found that the tumor was produced by more than only the T cells’ present genetic changes.

The Risk of Inherited Cancer Can Be Caused by Changes in DNA and Other Biological Pathways
Biotechnology Cancer Research

The Risk of Inherited Cancer Can Be Caused by Changes in DNA and Other Biological Pathways

Editor's Desk 18 February 2025

According to the researchers, these recurring patterns suggest potential therapeutic targets meant to prevent or slow the progression of cancer.

Patients With Kidney Cancer in Stages III and IV May Benefit from the Cancer Vaccination
Cancer Clinical Trials Research

Patients With Kidney Cancer in Stages III and IV May Benefit from the Cancer Vaccination

Ajmal Aseem 6 February 2025

Surgery to remove the tumor is the standard of care for individuals with stage III or IV clear cell renal cell carcinoma.

Posts pagination

1 2 3 4 Next

Areas Covered

  • Anti-obesity Drugs
  • Applications of Biotechnology
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Staining
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • AstraZeneca is Hiring an AI Engineer – Lead Consultant in Chennai, India – May 2025
  • Schrödinger is Hiring a Quality Assurance Associate – Hyderabad, India – May 2025
  • Roche Hiring Veeva Vault Business Systems Analysis Expert – Pune, India
  • Amgen Hiring Senior Data Engineer in Hyderabad, India – May 2025
  • Novo Nordisk Hiring Senior Regulatory Affairs Specialist in Seoul, South Korea – May 2025
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy